An estrogen sulfotransferase inhibitor composition comprises a compound of the formula ##STR1## wherein R.sub.1 is Br, NO.sub.2, or H; R. sub.2 is Br, NO.sub.2, NH.sub.2, or H; R is H or alkyl of 1-4 carbon atoms; R.sub.3 is O or H.sub.2 ; and R.sub.4 is H.sub.2, O, or &agr;-H, &bgr;-OH, in admixture with a pharmaceutically acceptable carrier. The specificity of the invention is believed targeted to the substituent at R. sub.2 or C.sub.4 and secondarily the OR group at C.sub.3.
展开▼
机译：雌激素磺基转移酶抑制剂组合物包含式## STR1 ##的化合物，其中R.sub.1是Br，NO.sub.2或H; R.sub.2是Br，NO.sub.2，NH.sub.2或H; R为H或1-4个碳原子的烷基; R.sub.3是O或H.sub.2; R 4是与药学上可接受的载体混合的H 2，O或α-H，b-OH。据信本发明的特异性针对R.sub.2或C.sub.4的取代基，其次是C.sub.3的OR基团。
展开▼
